Results 81 to 90 of about 35,850 (270)

Surgery for rheumatic mitral valve disease in sub-saharan African countries: why valve repair is still the best surgical option

open access: yesThe Pan African Medical Journal, 2016
Rheumatic valve disease, a consequence of acute rheumatic fever, remains endemic in developing countries in the sub-Saharan region where it is the leading cause of heart failure and cardiovascular death, involving predominantly a young population.
Charles Mve Mvondo   +6 more
doaj   +1 more source

Is mitral valve repair superior to replacement for chronic ischemic mitral regurgitation with left ventricular dysfunction?

open access: yesJournal of Cardiothoracic Surgery, 2010
Background This study was undertaken to compare mitral valve repair and replacement as treatments for ischemic mitral regurgitation (IMR) with left ventricular dysfunction (LVD).
Liu LeLe   +6 more
doaj   +1 more source

Relaxin mimetic in pulmonary hypertension associated with left heart disease: Design and rationale of Re‐PHIRE

open access: yesESC Heart Failure, EarlyView.
Abstract Aims Despite receiving guideline‐directed medical heart failure (HF) therapy, patients with pulmonary hypertension associated with left heart disease (PH‐LHD) experience higher mortality and hospitalization rates than the general HF population.
Marcin Ufnal   +17 more
wiley   +1 more source

Mitral Valve Repair: The Chordae Tendineae

open access: yesJournal of Tehran University Heart Center, 2015
Repair of the mitral valve is the treatment of choice for mitral valve regurgitation when the anatomy is favorable. It is well known that mitral valve repair enjoys better clinical and functional results than any other type of valve substitute. This fact
Carlos-A Mestres, José M Bernal
doaj  

Temporal profiling of M‐TEER‐related complications

open access: yesESC Heart Failure, EarlyView.
Abstract Aims Transcatheter edge‐to‐edge repair of the mitral valve (M‐TEER) is known for its low complication rates. However, the optimal level and duration of post‐procedural care remain unclear. This study aimed to identify the specific timeframe of post‐procedural complications following M‐TEER.
Jafer Haschemi   +8 more
wiley   +1 more source

Comparative results of repair of Ischemic Mitral Regurgitation (IMR): Conventional against Trans-Septal Approach

open access: yesInternational Journal of Endorsing Health Science Research, 2017
Objective: Ischemic mitral regurgitation is common and increases mortality, even when mild. (American Heart Association) AHA and European association have both stressed the need of mitral valve repair in patients with moderate or more regurgitation.
Ahson Memon   +6 more
doaj   +1 more source

Transcatheter edge‐to‐edge repair of atrial secondary mitral regurgitation positively influences atrial remodelling

open access: yesESC Heart Failure, EarlyView.
Abstract Background Atrial secondary mitral valve regurgitation (ASMR) is a distinct anatomical subset of secondary mitral regurgitation (SMR). Evidence of the effect of transcatheter edge‐to‐edge repair (TEER) on left atrial (LA) anatomy and function, especially reverse remodelling (LARR), is still sparse.
Aniela Petrescu   +10 more
wiley   +1 more source

Mitral valve surgery for mitral regurgitation caused by Libman-Sacks endocarditis: a report of four cases and a systematic review of the literature

open access: yesJournal of Cardiothoracic Surgery, 2010
Libman-Sacks endocarditis of the mitral valve was first described by Libman and Sacks in 1924. Currently, the sterile verrucous vegetative lesions seen in Libman-Sacks endocarditis are regarded as a cardiac manifestation of both systemic lupus ...
Bijl Marc   +8 more
doaj   +1 more source

Right ventricular reserve post mitral valve repair is associated with heart failure hospitalization

open access: yesPulmonary Circulation, 2020
Right ventricular impairment is a predictor of cardiovascular outcomes in patients with degenerative mitral regurgitation. However, the time course of right ventricular functional changes post-surgical mitral valve repair remains largely unknown. Herein,
Wei-Ting Chang   +5 more
doaj   +1 more source

Clinical utility and safety of finerenone in patients with heart failure: Rationale and design of FINE registry

open access: yesESC Heart Failure, EarlyView.
Abstract Aims Information about current use of finerenone in patients with heart failure (HF) finerenone in clinical practice is scarce, and its effectiveness in clinical practice in patients is scarce. We aim to assess both the baseline clinical profile and prognostic role of finerenone in patients with HF, irrespective of ejection fraction.
Gonzalo Luis Alonso Salinas   +32 more
wiley   +1 more source

Home - About - Disclaimer - Privacy